✦ LIBER ✦

Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells

✍ Scribed by Dharminder Chauhan; Madhavi Bandi; Ajita V. Singh; Arghya Ray; Noopur Raje; Paul Richardson; Kenneth C. Anderson

Book ID: 108677459
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 728 KB
Volume: 155
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2011.08888.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

299 Preclinical in vivo evaluation of a

299 Preclinical in vivo evaluation of a doxorubicin-antibody conjugate for treating multiple myeloma

✍ G.L. Griffiths; P. Sapra; J. Pickett; T. Cardillo; R. Stein; S.V. Govindan; A. S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 274 KB

Preclinical Pharmacological Evaluation o

Preclinical Pharmacological Evaluation of a Novel Multiple Kinase Inhibitor, ON123300, in Brain Tumor Models

✍ Zhang, X.; Lv, H.; Zhou, Q.; Elkholi, R.; Chipuk, J. E.; Reddy, M. V. R.; Reddy, 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 977 KB

Preclinical activity of P276-00, a novel

Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma

✍ Raje, N; Hideshima, T; Mukherjee, S; Raab, M; Vallet, S; Chhetri, S; Cirstea, D; 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 354 KB

P21. Myeloma cells decrease EphB4 expres

P21. Myeloma cells decrease EphB4 expression in osteoblasts: A novel mechanism for regulation of bone formation in multiple myeloma

✍ Andreia Bates; Gregory Mundy; Claire Edwards 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 29 KB

Novel evidence of a role for chromosome

Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma

✍ Patricia Le Baccon; Dominique Leroux; Christina Dascalescu; Samuel Duley; Daniel 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

## Abstract 1q rearrangement is a remarkably frequent secondary chromosomal change in both non‐Hodgkin's lymphoma (NHL) and multiple myeloma (MM), where it is associated with tumor progression. To gain insight into 1q rearrangement‐associated disease mechanisms, we used fluorescence in situ hybridi

Evaluation of the novel mitotic modulato

Evaluation of the novel mitotic modulator ON 01910.Na in pancreatic cancer and preclinical development of an ex vivo predictive assay

✍ Jimeno, A; Chan, A; Cusatis, G; Zhang, X; Wheelhouse, J; Solomon, A; Chan, F; Zh 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 259 KB